Who do you relate to more when it comes to diabetes management? An angel who follows the recommended guidelines (Jeremy/Gallant), or a stubborn hellion easily influenced by temptation (Steve/Goofus)? Check out some of these scenarios from Dr. E. and see if you are who you think you are.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/01/the-goofus-and-gallant-of-diabetes/" align="left"]
With recent news about SGLT2s and GLP-1 RAs helping to protect against heart disease in addition to their primary purpose of lowering blood sugars, Dr. Edelman addresses the question of whether it’s safe to take them together, and if they can also cause hypoglycemia.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/10/cardiovascular-benefits-of-sglt2-inhibitors-glp-1-ras/" align="left"]
With newer medication options available now for treating type 2 diabetes, Dr. Edelman answers a common question about how they can be included in a diabetes management regimen with regard to metformin.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/08/are-glp-1s-and-sglt2s-replacements-for-metformin-or-in-addition-to-metformin/" align="left"]
Did you know that certain aspects of type 2 diabetes can change over time? Even if you’ve had years of great blood sugar control, you still may need to make some medication adjustments down the road, and that’s totally normal.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/06/dont-let-your-fear-of-the-needle-stop-you-from-taking-control/" align="left"]
Trijardy is the first triple combo pill for people with type 2 diabetes that combines three meds in one. It helps reduce blood sugar, promote weight loss, improve blood pressure and reduce the risk of coronary artery disease, renal disease and strokes.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/03/trijardy-xr-the-first-triple-combo-pill-for-type-2-diabetes/" align="left"]
